Meridian Bioscience VIVO
$ 33.97
0.0%
Quarterly report 2022-Q4
added 02-09-2023
Country |
USA |
IPO year |
1986 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. John Kenny |
Employees in the company |
660 |
Shares |
43.6 M |
Market Cap[1] |
$ 1.49 B |
EBITDA (LTM) |
$ 52.9 M |
P/E (LTM) |
56.62 |
P/S (LTM) |
4.65 |
EPS (LTM) |
0.6 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.